SINGLETON J MATTHEW
SEC insider (Form 3/4/5 filer). CIK 0001243514. Director at Viking Therapeutics, Inc. (VKTX). 6 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in SAN DIEGO, CA.
Companies SINGLETON J MATTHEW has filed insider reports for
- Viking Therapeutics, Inc. (VKTX): Director
SINGLETON J MATTHEW
CIK: 0001243514
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Viking Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jan 2, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect3.2K shares- - Jan 2, 2025VKTX
Viking Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18.8K shares- - Oct 25, 2024VKTX
Viking Therapeutics, Inc.
ExerciseDirect16K shares at avg. $4.48$72K - Oct 25, 2024VKTX
Viking Therapeutics, Inc.
SaleDirect16K shares at avg. $79.50$1.3M - Sep 20, 2024VKTX
Viking Therapeutics, Inc.
ExerciseDirect10.3K shares at avg. $1.19$12K - Sep 20, 2024VKTX
Viking Therapeutics, Inc.
SaleDirect10.3K shares at avg. $69.50$716K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | Award | 3,150 | - | $0 | Direct |
| Jan 2, 2025 | VKTX Viking Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,800 | - | - | Direct |
| Oct 25, 2024 | VKTX Viking Therapeutics, Inc. | Exercise | 16,000 | $4.48 | $71,680 | Direct |
| Oct 25, 2024 | VKTX Viking Therapeutics, Inc. | Sale | 16,000 | $79.50 | $1,272,000 | Direct |
| Sep 20, 2024 | VKTX Viking Therapeutics, Inc. | Exercise | 10,300 | $1.19 | $12,257 | Direct |
| Sep 20, 2024 | VKTX Viking Therapeutics, Inc. | Sale | 10,300 | $69.50 | $715,850 | Direct |
1-6 of 6 transactions